Study asks why uptake of bivalent COVID boosters low
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
FDA advisory panel recommends Omicron-containing booster shots
The Updated COVID Boosters Could Have Been Better | MedPage Today
Updated Covid boosters cut the infection risk from XBB.1.5 subvariant by half, CDC finds
Updated boosters add limited protection against Covid-19 illness, first real-world study shows | CNN
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Bivalent mRNA booster effective, 'essential' for older adults
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
New Omicron-specific vaccines offer similar protection to existing boosters
Bivalent Moderna vaccine effective against Omicron sub-variants - Hospital Pharmacy EuropeHospital Pharmacy Europe
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
Why and When to Get a Bivalent Covid-19 Booster | Johns Hopkins | Bloomberg School of Public Health
Why payers should be preparing now for new COVID-19 boosters
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
:max_bytes(150000):strip_icc()/Booster-Shot-GettyImages-1362497127-e10ca9b1e3e5424db126022a8dc254bf.jpg "How Effective Are the Bivalent Boosters? CDC Shares New Data")
How Effective Are the Bivalent Boosters? CDC Shares New Data
